<SEC-DOCUMENT>0001193125-23-270359.txt : 20231103
<SEC-HEADER>0001193125-23-270359.hdr.sgml : 20231103
<ACCEPTANCE-DATETIME>20231103160238
ACCESSION NUMBER:		0001193125-23-270359
CONFORMED SUBMISSION TYPE:	424B5
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20231103
DATE AS OF CHANGE:		20231103

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			WATSCO INC
		CENTRAL INDEX KEY:			0000105016
		STANDARD INDUSTRIAL CLASSIFICATION:	WHOLESALE-HARDWARE & PLUMBING & HEATING EQUIPMENT & SUPPLIES [5070]
		IRS NUMBER:				590778222
		STATE OF INCORPORATION:			FL
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B5
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-260758
		FILM NUMBER:		231376241

	BUSINESS ADDRESS:	
		STREET 1:		2665 S BAYSHORE DR
		STREET 2:		STE 901
		CITY:			COCONUT GROVE
		STATE:			FL
		ZIP:			33133
		BUSINESS PHONE:		305-714-4100

	MAIL ADDRESS:	
		STREET 1:		2665 SOUTH BAYSHORE DR, STE 901
		CITY:			COCONUT GROVE
		STATE:			FL
		ZIP:			33133
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B5
<SEQUENCE>1
<FILENAME>d897436d424b5.htm
<DESCRIPTION>424B5
<TEXT>
<HTML><HEAD>
<TITLE>424B5</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Filed pursuant to Rule 424(b)(5) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Registration <FONT STYLE="white-space:nowrap">No.&nbsp;333-260758</FONT> </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Supplement No.&nbsp;2 dated November&nbsp;3, 2023 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To Prospectus
Supplement dated November&nbsp;4, 2021 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">as supplemented by Supplement No 1., dated February&nbsp;25, 2022 </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(To Prospectus dated November&nbsp;4, 2021) </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">$300,000,000 </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g897436g1101192523601.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman" ALIGN="center"><B>Watsco, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Common stock </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This supplement
no. 2, referred to as this Supplement, supplements certain information contained in the prospectus supplement dated November&nbsp;4, 2021, as supplemented by supplement no. 1 dated February&nbsp;25, 2022, referred to as the prospectus supplement,
relating to the issuance and sale of shares of our Common stock, par value $0.50 per share, referred to as the Common stock, having an aggregate gross sales price of up to $300,000,000 from time to time through Robert W. Baird&nbsp;&amp; Co.
Incorporated, referred to as Baird, acting as agent or principal, in negotiated transactions or transactions that are deemed to be &#147;at the market&#148; offerings as defined in Rule 415 under the Securities Act of 1933, as amended, referred to
as the Securities Act, including sales made directly on the New York Stock Exchange, or the NYSE, or sales made to or through a market maker other than on an exchange. This Supplement should be read in conjunction with the prospectus supplement and
the prospectus dated November&nbsp;4, 2021 to which the prospectus supplement relates. Capitalized terms used in this Supplement and not defined herein have the respective meanings ascribed to such terms in the prospectus supplement. This Supplement
amends only those sections of the prospectus supplement contained in this Supplement; all other sections of the prospectus supplement remain unchanged. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">This Supplement is being filed to reflect the second amendment and restatement on November&nbsp;3, 2023, of that certain amended and restated
sales agreement dated February&nbsp;25, 2022, which we refer to as the second amended and restated sales agreement, between us and Baird, which removes Goldman Sachs&nbsp;&amp; Co. LLC, referred to as Goldman Sachs, as an agent under the second
amended and restated sales agreement. Accordingly, each reference to the term &#147;agents&#148; in the prospectus supplement is hereby amended to refer to &#147;agent&#148; and shall not include Goldman Sachs and each reference to the term
&#147;amended and restated sales agreement&#148; in the prospectus supplement is hereby amended to refer to the second amended and restated sales agreement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As of the date of this Supplement, we have sold 45,000 shares of our Common stock under the amended and restated sales agreement for an
aggregate gross sales price of $15,255,000; consequently, shares of Common stock having an aggregate gross sales price of $284,745,000 currently remain available for sale under the second amended and restated sales agreement, the prospectus
supplement, this Supplement and the accompanying prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Our Common stock is listed on the New York Stock Exchange under the ticker
symbol &#147;WSO.&#148; On November&nbsp;2, 2023, the last reported sale price for our Common stock was $361.93 per share. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman"><B><I>Investing in our securities involves risks. See &#147;Risk Factors&#148; beginning on
page <FONT STYLE="white-space:nowrap">S-3</FONT> of the prospectus supplement. </I></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">NEITHER THE SECURITIES AND
EXCHANGE COMMISSION NOR ANY STATE SECURITIES COMMISSION HAS APPROVED OR DISAPPROVED OF THESE SECURITIES OR DETERMINED IF THIS SUPPLEMENT, THE PROSPECTUS SUPPLEMENT OR THE ACCOMPANYING PROSPECTUS IS TRUTHFUL OR COMPLETE. ANY REPRESENTATION TO THE
CONTRARY IS A CRIMINAL OFFENSE. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Baird </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The date of this
Supplement is November&nbsp;3, 2023. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The following section of the prospectus supplement is hereby amended and restated as follows: </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PLAN OF DISTRIBUTION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We
have entered into a second amended and restated sales agreement, dated November&nbsp;3, 2023, with Robert W. Baird&nbsp;&amp; Co. Incorporated, the agent, which amends and restates that certain amended and restated sales agreement, dated
February&nbsp;25, 2022, under which we may from time to time offer and sell shares of our Common stock having an aggregate gross sales price of up to $300,000,000. The second amended and restated sales agreement amends and restates the amended and
restated sales agreement under our shelf registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> (File <FONT STYLE="white-space:nowrap">No.&nbsp;333-260758),</FONT> to remove references to Goldman Sachs&nbsp;&amp; Co. LLC as an
agent thereunder. As of November&nbsp;3, 2023, we had sold 45,000 shares of our Common stock under the amended and restated sales agreement for an aggregate gross sales price of $15,255,000; consequently, shares of Common stock having an aggregate
gross sales price of $284,745,000 currently remain available for sale pursuant to the second amended and restated sales agreement and under the prospectus supplement, this Supplement and the accompanying prospectus. Further sales of shares of our
Common stock, if any, under this prospectus supplement<I> </I>and the accompanying prospectus may be made in transactions that are deemed to be &#147;at the market&#148; offerings as defined in Rule 415 under the Securities Act, including sales made
directly on the NYSE or sales made to or through a market maker other than on an exchange, or in negotiated transactions, which may include block trades. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The offering of the shares of our Common stock by the agent is subject to receipt and acceptance of written instructions and subject to the
agent&#146;s right to decline any order in whole or in part. Upon its acceptance of a placement notice from us, the agent will use its commercially reasonable efforts consistent with its normal sales and trading practices to solicit offers to
purchase shares of our Common stock up to the amount specified, and in accordance with the terms and conditions set forth in the second amended and restated sales agreement. The placement notice that we deliver will set forth the number of shares to
be issued, the time period during which sales are requested to be made by the agent, any limitation on the number of shares that may be sold in any one trading day and any minimum price below which sales may not be made. We or the agent may suspend
the offering of shares of our Common stock upon proper notice and subject to other conditions. There is no arrangement for funds to be received in an escrow, trust or similar account. Sales of shares of our Common stock as contemplated by this
prospectus supplement<B> </B>will be settled through the facilities of DTC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The agent will provide written confirmation to us no later
than the opening of the trading day on the NYSE on the day following the trading day on which shares of our Common stock were sold under the second amended and restated sales agreement. Each confirmation will include the number of shares sold on the
relevant day, the net proceeds to us and the compensation payable by us to the agent in connection with the sales. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will pay the agent
commissions for its services in acting as agent and/or principal in the sale of shares of our Common stock. The agent will be entitled to compensation of up to 2.0% of the gross sales price of all shares of Common stock sold through it pursuant to
the second amended and restated sales agreement. We estimate that the total expenses for the offering, excluding compensation payable to the agent under the terms of the second amended and restated sales agreement, will be approximately $140,000,
inclusive of the SEC registration fee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We may also sell shares of our Common stock to the agent as principal for its own account at a
price agreed upon at the time of sale. If we sell shares of our Common stock to the agent as principal, we will enter into a separate agreement with the agent setting forth the terms of such transaction, and, to the extent required by applicable
law, we will describe this agreement in a separate prospectus supplement or pricing supplement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We will report at least quarterly the
number of shares of our Common stock sold through the agent under the second amended and restated sales agreement, the net proceeds to us and the compensation paid by us to the agent in connection with the sales of shares of our Common stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The agent and its affiliates have provided, and may in the future provide, various
investment banking, commercial banking, fiduciary and advisory services for us from time to time for which they have received, and may in the future receive, customary fees and expenses. The agent and its affiliates may, from time to time, engage in
other transactions with and perform services for us in the ordinary course of their business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the ordinary course of their business
activities, the agent and its affiliates may make or hold a broad array of investments and actively trade debt and equity securities (or related derivative securities) and financial instruments (including bank loans) for their own account and for
the accounts of their customers. Such investments and securities activities may involve securities and/or instruments of ours or our affiliates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In connection with the sale of shares of our Common stock on our behalf, the agent may be deemed to be an &#147;underwriter&#148; within the
meaning of the Securities Act and the compensation of the agent may be deemed to be underwriting commissions or discounts. We have agreed to indemnify the agent against specified liabilities, including liabilities under the Securities Act, or to
contribute to payments that the agent may be required to make because of those liabilities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The offering of shares of our Common stock
pursuant to the second amended and restated sales agreement will terminate upon the earlier of (1)&nbsp;the sale of shares of Common stock under the second amended and restated sales agreement having an aggregate gross sales price of $300,000,000
and (2)&nbsp;the termination of the second amended and restated sales agreement. The second amended and restated sales agreement may be terminated by the agent at any time by giving us three days&#146; notice, by us at any time, and by the agent at
any time in certain circumstances, including the occurrence of a material adverse change in our company. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g897436g1101192523601.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g897436g1101192523601.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  O -D# 2(  A$! Q$!_\0
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#?__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
